GRIFOLS | GRF - Net Income


GRIFOLS reported EUR73M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Alcon AG USD 189M 28M Mar/2026
Almirall EUR 19.58M 7M Dec/2025
Amadeus IT EUR 357M 109.5M Mar/2026
Amarin USD -1.22M 6.51M Dec/2025
argenx SE USD 366M 166.95M Mar/2026
AstraZeneca USD 3.08B 754M Mar/2026
Bayer EUR 2.76B 6.52B Mar/2026
Cie Automotive EUR 149.91M 35.97M Dec/2025
Demant DKK 427M 690M Dec/2025
Ence Energia y Celulosa EUR -32.46M 17.36M Dec/2025
Essilor EUR 928M 459M Dec/2025
Ferrovial EUR 348M 192M Dec/2025
Fresenius EUR 361M 17M Dec/2025
Fresenius Medical Care EUR 118M 209M Mar/2026
Genmab DKK 31M 370M Dec/2025
GlaxoSmithKline GBP 1.74B 1.1B Mar/2026
GRIFOLS EUR 73M 25.25M Mar/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Inditex EUR 1.38B 223M Mar/2026
Lakefront Biotherapeutics EUR 14.49M 767.65M Mar/2026
Merck EUR 659M 340M Mar/2026
Novartis USD 3.16B 747M Mar/2026
Philips EUR 151M 244M Mar/2026
Roche Holding CHF 5.47B 1.76B Dec/2025
Sanofi EUR 1.61B 2.42B Mar/2026
Smith & Nephew USD 293M 79M Dec/2025
UCB EUR 1.08B 608M Dec/2025
Viscofan EUR 33.67M 17.61M Mar/2026